Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study

NCT05271370 is registered in ClinicalTrials.gov with CytoDyn, Inc. as lead sponsor.

NCT NCT05271370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05271370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study
Lead sponsor
CytoDyn, Inc.
Phase
Phase 2/3
Overall status
Terminated
Start date
August 29, 2017
Completion date
July 10, 2022
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection